2009 | | Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm | 김재근, 양민재, 왕희정, 원제환, 정재연, 조성원 |
2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
2014 | | Embolization of percutaneous transhepatic portal venous access tract with N-butyl cyanoacrylate. | 김봉완, 김순선, 김진우, 왕희정, 원제환, 정재연, 조성원 |
2011 | | Endoscopic treatment of a large gastric duplication cyst with hook-knife and snare (with video). | 김영배, 김재근, 김진홍, 신성재, 유병무, 이기명, 임선교, 정재연, 황재철 |
2015 | | High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation. | 김봉완, 김순선, 김재근, 노충균, 신성재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정 |
2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
2015 | | Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization. | 강대용, 김순선, 김재근, 박주한, 신성재, 원제환, 유병무, 이기명, 이제희, 정재연, 조성원, 조효정 |
2004 | | Intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein thrombosis | 김재근, 김진홍, 왕희정, 원제환, 이기명, 정재연, 조성원, 함기백 |
2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
2015 | | Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment. | 김순선, 김재근, 박주한, 왕희정, 정재연, 조성원, 조효정 |
2005 | | MR findings in eosinophilic infiltration of the liver. | 김영배, 김재근, 선주성, 원제환, 이기명, 정재연 |
2013 | | Novel method of stent insertion for malignant lower rectal obstruction with proximal releasing delivery system (with video). | 김재근, 김진홍, 신성재, 유병무, 이기명, 임선교, 정재연, 황재철 |
2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
2010 | | Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis | 김재근, 정재연, 조성원 |
2013 | | Radiofrequency ablation of metastatic liver masses: recurrence patterns and prognostic factors based on radiologic features. | 김재근, 김태희, 박미진, 이기명, 정재연 |
2012 | | Revision and update on clinical practice guideline for liver cirrhosis | 김재근, 정재연, 조성원 |
2005 | | Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. | 김재근, 김진홍, 왕희정, 원제환, 이기명, 정재연, 조성원, 함기백 |
2010 | | Tracking of transplanted mesenchymal stem cells labeled with fluorescent magnetic nanoparticle in liver cirrhosis rat model with 3-T MRI. | 김선용, 김재근, 김태희, 박태준, 정재연 |